Teva Pharmaceutical Industries LtdTEVA
What Teva Pharmaceutical Industries Ltd does.
We are a biopharmaceutical company, enabled by a world-class generics business. For over 120 years, our commitment to bettering health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, we are dedicated to addressing patients’ needs, now and in the future.
We operate worldwide, with headquarters in Israel and a significant presence in the United States, Europe and many other markets around the world. Today, our global network of capabilities consists of approximately 34,000 employees across 57 markets.
Teva was incorporated in Israel on February 13, 1944 and is the successor to a number of Israeli corporations, the oldest of which was established in 1901.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $16.7B | $15.9B | $14.9B | $15.8B | $16.5B | $17.3B |
| Net income | -$4.0B | $417.0M | -$2.4B | -$559.0M | -$1.6B | $1.4B |
| Free cash flow | $638.0M | $236.0M | $1.0B | $842.0M | $749.0M | $1.1B |
More on TEVA.
- Teva Pharmaceutical Industries Ltd summary
- Teva Pharmaceutical Industries Ltd financial statements
- Teva Pharmaceutical Industries Ltd key metrics
- Teva Pharmaceutical Industries Ltd health scores and style box
- Teva Pharmaceutical Industries Ltd earnings
- Teva Pharmaceutical Industries Ltd dividends
- Teva Pharmaceutical Industries Ltd valuation
- Teva Pharmaceutical Industries Ltd ownership and insiders
- Teva Pharmaceutical Industries Ltd peers
Figures from Teva Pharmaceutical Industries Ltd's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.